A recent study suggests that individuals who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who end traditional lifestyle programs.
Published data in a major medical journal demonstrates that while obese people often shed substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying such drugs must be informed of the risk of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment mass in about a year and a half.
Comparing Approaches
The research, which looked at 37 of trials involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
The team emphasize that individuals who lose weight through lifestyle changes alone generally have a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Doctors believe the way of the drugs explains the accelerated rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating far more likely."
A Lifelong Condition?
Medical guidelines suggest the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals contend that, considering the significant potential of weight regain, the treatment might need to be life-long.
This view is supported by pharmaceutical companies, who state that the findings "emphasize the chronic character of obesity," similar to managing conditions like high blood pressure.
User Accounts
People who have stopped the jabs explain a sudden resurgence of cravings.
"It felt as if something that goes on and you become starving," described an individual.
This challenge is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during treatment.
Significant Use
Figures suggest that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, clinicians caution that while these medications are powerful agents for shedding pounds, they are not a magic solution and long-term success relies on integrated lifestyle management.
